-
![]()
143
-
WHO-Infection prevention and control in the context of coronavirus disease ( COVID-19) - a living guideline, 9 October 2023.pdf
- WHO-Infection prevention and control in the context of coronavirus disease ( COVID-19) - a living guideline, 9 October 2023WHO-Infection prevention and control in the context of coronavirus disease ( COVID-19) - a living guideline, 9 October 2023WHO-Infection prevention and control in the context of coronavirus disease ( COVID-19) - a living guideline, 9 October 2023
-
-
![]()
190
-
who -Infection prevention and control guideline for Ebola and Marburg disease, August 2023.pdf
- who -Infection prevention and control guideline for Ebola and Marburg disease, August 2023who -Infection prevention and control guideline for Ebola and Marburg disease, August 2023who -Infection prevention and control guideline for Ebola and Marburg disease, August 2023
-
-
![]()
102
-
who -Infection prevention and control in the context of coronavirus disease (COVID-19)- a living guideline, 10 August 2023.pdf
- who -Infection prevention and control in the context of coronavirus disease (COVID-19)- a living guideline, 10 August 2023who -Infection prevention and control in the context of coronavirus disease (COVID-19)- a living guideline, 10 August 2023who -Infection prevention and control in the context of coronavirus disease (COVID-19)- a living guideline, 10 August 2023
-
-
![]()
65
-
who -WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition use of mRNA tests for human papillomavirus ( HPV).pdf
- who -WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition use of mRNA tests for human papillomavirus ( HPV)who -WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition use of mRNA tests for human papillomavirus ( HPV)who -WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition use of mRNA tests for human papillomavirus ( HPV)
-
-
![]()
146
-
WHO guideline on control and elimination of human schistosomiasis.pdf
- WHO guideline on control and elimination of human schistosomiasisWHO guideline on control and elimination of human schistosomiasisWHO guideline on control and elimination of human schistosomiasis
-
-
![]()
219
-
evidence-based guideline diagnosis and treatment :基于诊断治疗指南的证据.doc
- evidence-based guideline diagnosis and treatment ：基于诊断治疗指南的证据
-
-
![]()
40
-
who -COVID-19 infection prevention and control living guideline - mask use in community settings, 22 December 2021.pdf
- who -COVID-19 infection prevention and control living guideline - mask use in community settings, 22 December 2021who -COVID-19 infection prevention and control living guideline - mask use in community settings, 22 December 2021who -COVID-19 infection prevention and control living guideline - mask use in community settings, 22 December 2021
-
-
![]()
92
-
who -Use of non-sugar sweeteners- WHO guideline.pdf
- who -Use of non-sugar sweeteners- WHO guidelinewho -Use of non-sugar sweeteners- WHO guidelinewho -Use of non-sugar sweeteners- WHO guideline
-
-
![]()
102
-
who -Carbohydrate intake for adults and children - WHO guideline.pdf
- who -Carbohydrate intake for adults and children - WHO guidelinewho -Carbohydrate intake for adults and children - WHO guidelinewho -Carbohydrate intake for adults and children - WHO guideline
-
向豆丁求助：有没有afsa guideline?
